Results 71 to 80 of about 780 (113)

Efficacy and safety of therapeutic vaccines for the treatment of chronic hepatitis B: A systematic review and meta-analysis of randomized controlled trials update. [PDF]

Medicine (Baltimore)
Geta M, Geta M, Mengistu G, Yizengaw E, Manyzewal T, Hailu A, Woldeamanuel Y.   +6 more
europepmc   +1 more source

Patients with chronic hepatitis B under nucleos(t)ide analog therapy with Omicron BA.5 infection: A retrospective study in South China. [PDF]

Liver Res
Wang P, Chen J, Chen D, Lei Z, Mo Z, Zhang Y.   +5 more
europepmc   +1 more source

Two Concepts of Hepatitis B Core-Related Antigen Assay: A Highly Sensitive and Rapid Assay or an Effective Tool for Widespread Screening. [PDF]

Viruses
Inoue T, Yagi S, Tanaka Y.
europepmc   +1 more source

Hepatitis B Virus Prevalence and Transmission in the Households of Pregnant Women in Kinshasa, Democratic Republic of Congo. [PDF]

Open Forum Infect Dis
Morgan CE, Ngimbi P, Boisson-Walsh AJN, Ntambua S, Matondo J, Tabala M, Kashamuka MM, Emch M, Edwards JK, Powers KA, James L, Mbonze N, Mampunza S, Yotebieng M, Thompson P, Parr JB.   +15 more
europepmc   +1 more source

Antibody levels and immune memory in children with kaposiform hemangioendothelioma treated with sirolimus after catch up vaccination. [PDF]

Hum Vaccin Immunother
Yuan J, Ding Y, Wang Z, Su L, Li K.
europepmc   +1 more source

Decoding the cross-immune pressure: Dengue's role in SARS-CoV-2 evolution. [PDF]

Comput Struct Biotechnol J
Mallick A, Chhajer R, Biswas S.
europepmc   +1 more source

Combating respiratory diseases with mucosal vaccines. [PDF]

J Virol
Tang PCH, Ling Z, Lee M, King NJC, Mahalingam S.   +4 more
europepmc   +1 more source

Results of Nucleos(t)ide Analog Treatment Discontinuation in Hepatitis B e-Antigen-Negative Chronic Hepatitis B: NUCSTOP Study. [PDF]

Turk J Gastroenterol
Kiremitçi S, Koçhan K, Seven G, Biberci Keskin E, Okay G, Akkoyunlu Y, Meriç Koç M, Sümbül B, Şentürk H.   +8 more
europepmc   +1 more source

The potential of HBV cure: an overview of CRISPR-mediated HBV gene disruption. [PDF]

Front Genome Ed
Yao ZQ, Schank MB, Zhao J, El Gazzar M, Wang L, Zhang Y, Hill AC, Banik P, Pyburn JS, Moorman JP.   +9 more
europepmc   +1 more source